The price of IGC Pharma Inc (AMEX: IGC) closed at $0.33 in the last session, down -2.23% from day before closing price of $0.33. In other words, the price has decreased by -$0.0074 from its previous closing price. On the day, 524485 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
We take a closer look at IGC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGC now has a Market Capitalization of 20.72M and an Enterprise Value of 19.72M. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.98 while its Price-to-Book (P/B) ratio in mrq is 2.29. Its current Enterprise Value per Revenue stands at 16.22 whereas that against EBITDA is -1.79.
Stock Price History:
Over the past 52 weeks, IGC has reached a high of $0.50, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.2976, while the 200-Day Moving Average is calculated to be 0.3213.
Shares Statistics:
According to the various share statistics, IGC traded on average about 423.76K shares per day over the past 3-months and 725.16k shares per day over the past 10 days. A total of 53.08M shares are outstanding, with a floating share count of 51.36M. Insiders hold about 19.42% of the company’s shares, while institutions hold 3.87% stake in the company. Shares short for IGC as of Feb 29, 2024 were 910.73k with a Short Ratio of 2.15, compared to 961.25k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.43% and a Short% of Float of 1.52%.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.22 and -$0.22 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.16, with 1 analysts recommending between -$0.16 and -$0.16.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $1.4M in the next fiscal year. The high estimate is $1.4M and the low estimate is $1.4M. The average revenue growth estimate for next year is up 12.90% from the average revenue estimate for this year.
